The Food and Drug Administration issued a request for information (RFI) on the critical scientific challenges and opportunities to advance the development of individualized cellular and gene therapies (CGTs). The agency notes that an improved understanding of the molecular basis of disease along with the availability of sensitive diagnostic tools has led to the increasing opportunity to create individualized products… (Slifer, September 20, 2023) #Food and Drug Administration